KELOWNA, British Columbia, May 18, 2017 /Weed Wire/ – Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is one of five companies featured on a special BTV episode exploring burgeoning cannabis enterprises.
Tag Archives: Kelowna
Lexaria Announces R&D on Nicotine
KELOWNA, British Columbia, May 4, 2017 /Weed Wire/ — Lexaria Bioscience Corp (OTCQB:LXRP) (CSE:LXX) (the “Company”, “Lexaria”) is announcing new plans to commence nicotine absorption research beginning in the summer of 2017, within its previously announced R&D budget that is fully funded.
Marapharm Ventures Inc. ‘Marapharm’ Announces an Online News Channel for Awareness of the Sector and of Marapharm
KELOWNA, British Columbia, April 28, 2017 /Weed Wire/ — Marapharm Ventures Inc. (OTCQB: MRPHF) is pleased to announce that it will be launching http://www.marapharm.tv on or before June 15, 2017.
Marapharm Ventures Inc. “Marapharm” announces an acquisition in California
KELOWNA, British Columbia, Feb. 21, 2017 /Weed Wire/ — Marapharm has entered into an agreement to purchase a Medical Delivery Service with the specific and limited purpose to deliver, facilitate or coordinate cannabis transactions between qualified patients and caregivers.
Lexaria Receives US$33,029.25 from Exercise of Options and Warrants
KELOWNA, British Columbia, Jan. 10, 2017 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces it has received US$33,029.25 from the exercise of stock options and warrants previously granted.
Lexaria Extends Investor Relations Agreement
KELOWNA, British Columbia, Dec. 22, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces it has extended the services of Frontier Merchant Capital Group (“Frontier”) with a head office in Toronto, Canada, for a period of three months. Lexaria will pay CDN $25,000 + GST.
Lexaria Files International Cannabinoid Patent Applications
KELOWNA, British Columbia, Dec. 19, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is pleased to announce, following the successful October 26, 2016 issuance of its U.S. Patent No. 9,474,725, Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof, it has filed to expand this patent internationally.
Lexaria Receives US$737,500 from Exercise of Warrants
KELOWNA, British Columbia, Dec. 2, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces it has received US$737,500 from the early exercise warrant incentive program announced on October 27, 2016.
Hempco Food and Fibre Inc. to Utilize Lexaria’s Patented Technology
KELOWNA, British Columbia, Nov. 30, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”) is pleased to announce the entry of a letter of intent (the “LOI”) for the licensing of its proprietary absorption and palatability enhancing technology to Hempco Food and Fiber Inc. (TSXV: HEMP) (“Hempco®”).
Lexaria Enters Memorandum of Understanding Establishing a Joint Venture with NeutriSci International Inc.
KELOWNA, British Columbia, Nov. 22, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) and NeutrisSci International Inc. (“Neutrisci”) (TSX-V:NU, Frankfurt-1N9) are pleased to announce the signing of a Memorandum of Understanding forming a 50/50 Joint Venture.
Lexaria Offers Warrant Holders Early Exercise Incentive
KELOWNA, British Columbia, Oct. 27, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) has received approval to offer existing warrant holders an incentive to exercise existing warrants early.
Lexaria Bioscience Announces Issuance of U.S. Patent for Cannabinoid Infused Edibles
KELOWNA, British Columbia, Oct. 26, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is pleased to announce the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 9,474,725 pertaining to Lexaria’s method of improving bioavailability and taste of certain cannabinoid lipophilic active agents in food products.
Lexaria Appoints New Auditors
KELOWNA, British Columbia,Oct. 6, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces it has appointed Davidson and Company, LLP, Chartered Professional Accountants, as its new independent registered public auditing firm for its fiscal year ending August 31, 2016.
Lexaria Signs New Definitive Technology Licensing and Private Label Agreements
KELOWNA, British Columbia, Sept. 8, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”) is proud to announce two important new developments.
Lexaria Closes Final Tranche of Fully Subscribed Financing
KELOWNA, British Columbia, Aug. 31, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces it has closed the final tranche of the private placement equity financing announced July 5. The Company is pleased that the financing was fully subscribed.
New LOI Signed to Out-License Lexaria’s Technology
KELOWNA, British Columbia, Aug. 30, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”) has entered a new letter of intent (LOI) to license its proprietary absorption and palatability enhancing technology for cannabinoids and other bioactive substances.
Laguna Blends Closes First Tranche of Private Placement for $406,800
KELOWNA, British Columbia, Aug. 26, 2016 /Weed Wire/ — Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Laguna”) is pleased to announce a first tranche closing of its it non-brokered private placement (the “Private Placement”).
Lexaria Closes Financing, Enhances Investor Relations Agreement
KELOWNA, British Columbia, Aug. 11, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces it has closed the private placement equity financing announced July 5.
Lexaria Signs Letter of Intent for Second Technology Out-Licensing Agreement including Plans to Enter Clinical Studies
KELOWNA, British Columbia, Aug. 10, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (“the Company” or “Lexaria”) has entered a letter of intent (LOI) to license its proprietary technology to CBDM LLC for the development and sale of a range of marijuana oil infused product.
Lexaria Enters Loan Agreement
KELOWNA, British Columbia, July 25, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is entering a loan agreement for the principal amount of US$50,000.
Lexaria Engages Respected Consulting and Finance Firms
KELOWNA, British Columbia, July 21, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is pleased to announce it has entered into two agreements with highly respected New York based firms.
Lexaria Receives Notice of Allowance of First Patent by US Patent Office
KELOWNA, British Columbia, July 12, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is very pleased to announce a watershed event in its advancement as a bioscience company: it has just received its first Notice of Allowance for one of its US patent applications from the US Patent and Trademark Office (USPTO).
Lexaria Intends to Complete an Equity Financing of US$300,000
KELOWNA, British Columbia, July 5, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered private placement financing of 5,000,000 equity units priced at US$0.06 (approx. CDN $0.078).
Lexaria Bioscience Added to CSE Composite Index
KELOWNA, British Columbia, June 21, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (CSE: LXX) is pleased to announce that it has been added to the Canadian Securities Exchange Composite Index.
Lexaria Closes Financing, Enters Investor Relations Agreement, Issues Options
KELOWNA, British Columbia, June 6, 2016 /Weed Wire/ —Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces it has closed the private placement equity financing announced May 31.
Lexaria Intends to Complete an Equity Financing of CDN$100,000
KELOWNA, British Columbia, May 31, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered private placement financing of 700,000 equity units priced at US$0.11.
Lexaria’s CEO Chris Bunka Will be Speaking at the Widely Acclaimed Cannabis Growth Capital Summit
KELOWNA, British Columbia, May 26, 2016 /Weed Wire/ — Lexaria is pleased to announce that CEO Chris Bunka will be speaking at the widely acclaimed Cannabis Growth Capital Summit on June 15 in New York. Investors and supports are encouraged to register for this highly anticipated event!